Medison Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Medison Pharma's estimated annual revenue is currently $125.2M per year.
- Medison Pharma's estimated revenue per employee is $201,000
Employee Data
- Medison Pharma has 623 Employees.
- Medison Pharma grew their employee count by 8% last year.
Medison Pharma's People
Name | Title | Email/Phone |
---|
Medison Pharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Medison Pharma?
Medison is one of the world's largest commercial partners of leading global biotech companies. Medison is uniquely qualified to provide the complete spectrum of integrated services for biotech companies looking to enter or expand their presence in Israel, Canada, and Central East Europe. Medison runs a corporate venture arm with a dedicated research and evaluation team boasting deep scientific and commercial backgrounds. Medison also operates a scouting program to cater to its partners and is an active investor in life science projects around drug development and digital health.
keywords:N/AN/A
Total Funding
623
Number of Employees
$125.2M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Medison Pharma News
At the end of March, Hansa and Medison Pharma announced that a marketing authorization was granted in Israel for Idefirix for...
Hansa and Medison Pharma announced that a marketing authorization in Israel for Idefirix® has been granted for desensitization treatment of...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $125.2M | 623 | 8% | N/A |
#2 | $446.4M | 981 | -1% | N/A |
#3 | $743.9M | 1968 | 6% | N/A |